section name header
Index
Aldosterone Receptor Antagonists Spironolactone and Eplerenone for Congestive Heart Failure
Antiplatelet Therapy for Prevention of Death, Myocardial Infarction, and Stroke
Cardiology…
Choice of Antihypertensive Drug in the Diabetic Patient from Prognostic Point of View
Comprehensive Treatment and Follow-Up of Type 2 Diabetes
Definition and Diagnosis of Dyslipidaemias
Diabetic Kidney Disease (Diabetic Nephropathy)
Diabetic Nephropathy - Related Resources
Endocrinology…
Ezetimibe for the Prevention of Cardiovascular Disease
Fibrates for Primary Prevention of Cardiovascular Disease
Fixed-Dose Combination Therapy for the Prevention of Atherosclerotic Cardiovascular Diseases
Glucagon-Like Peptide Analogues (GLP-1 Analogues) for Type 2 Diabetes
Interventions for Reversing Metabolic Syndrome
Lipid Lowering Therapies in Renal Disease
Low-Dose Aspirin for Prevention of Vascular Events in Type 2 Diabetes
Menopausal Hormone Therapy and the Risk of Stroke
Menopausal Symptoms and Hormone Therapy
Metabolic Syndrome
Oral Antidiabetic Drugs and GLP-1 Analogues
Pcsk9 Inhibitors for Prevention of Cardiovascular Disease
Pravastatin for Lowering Lipids
Prevention of Type 2 Diabetes in Persons at Increased Risk for the Development of T2d
Primary Hyperaldosteronism (Pha)
Reducing Cardiovascular Events by Multifactorial Intervention in Patients with Type 2 Diabetes
Sglt-2 Inhibitors and GLP-1 Agonists for Diabetes and Chronic Kidney Disease
Sglt-2 Inhibitors in Type 2 Diabetes
Statins for Improving Renal Outcomes
Statins for the Primary Prevention of Cardiovascular Disease
Surgery for Morbid Obesity
Treatment and Follow-Up in Type 2 Diabetes - Related Resources
Treatment of Dyslipidaemias
Treatment of Dyslipidaemias - Related Resources
Treatment of Hypertension JNC 7
Type 1 Diabetes: Treatment